Logo

Exiqon to Distribute FlexmiR MicroRNA Products Developed With Luminex

Jul 10, 2007
NEW YORK (GenomeWeb News) — Luminex and Exiqon have struck an agreement under which Exiqon will non-exclusively distribute a line of microRNA products the companies designed for Luminex’s xMAP platform in 2006.
 
The FlexmiR product line is based on Luminex’s xMAP technology and Exiqon’s locked nucleic acid technology.
 
The deal also gives Exiqon non-exclusive rights to sell Luminex systems worldwide.
 
Financial terms of the agreement were not released.
 
The companies claim FlexmiR can deliver more than 6,300 data points in four hours.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.